Innovative, Non-Invasive Benign Breast Tumor Treatment
Sarah Cannon at Rose Cancer Center, Denver, is proud to be one of the first hospitals in the nation to offer the Novilase ILT, a non-surgical treatment for benign (non-cancerous) breast tumors. Novilase ILT provides a minimally invasive alternative to a surgical lumpectomy to remove tumors. Rose Medical Center is one of only a few facilities in the U.S. participating in the Ablate Trial-- a clinical trial helping prove the effectiveness of laser ablation for small tumors. The hope is that in the future, some women may be able to treat their cancers without surgery.
For the last several years, Rose has been participating in this clinical trial, using the technology for malignant breast tumors. This method could dramatically change the traditional course of treatment for breast cancer patients.
To find out if you may be a candidate for the Novilase ILT clinical trial, please call 303-320-7138 or download our brochure.
Benign Breast Tumors
If your screening mammography and/or breast ultrasound reveals that you have a fibroadenoma(s), the most common type of solid, non-cancerous breast tumor, you and your doctors will discuss having the mass removed. Some patients choose not to have these tumors removed because it requires surgery with sedation. While the tumor itself is not harmful, additional, regular monitoring is necessary. Novilase provides an alternative to surgery, reducing continual monitoring, as well as providing piece of mind.
How it Works
Novilase ILT is an image-guided laser ablation device that can be used in an outpatient setting. The procedure is typically completed in about an hour. It is performed through two tiny "nicks", which are closed with band-aids, and uses a laser to heat the tumor until it dissolves. The Novilase procedure is shorter and less invasive in comparison to a lumpectomy, which requires sedation, lasts more than an hour, and includes a 2-3 inch incision that is closed with sutures.
As part of Novilase Interstitial Laser Therapy for the treatment of breast cancer, laser and thermal probes are inserted into the target tumor using imaging guidance. Real-time monitoring of temperature, shown in the graph at top left, is used to determine when the Novilase procedure is complete.